FOLLOW YOUR CURIOSITY
Browse all published resources below, or search for a compound, research question, or topic.
The resource library
48 resourcesA lack of cytotoxicity in fibroblast assays for TB-500 does not equate to organism-level safety. This article explains the limitations of in vitro cytotoxicity findings, the difference between cellular and systemic toxicity, and the need for broader safety evaluation, referencing recent analytical and biological studies.
Peptide cyclization is a chemical strategy that links the ends or side chains of a peptide to form a ring structure. This article explains the scientific rationale, experimental approaches, and research motivations for cyclizing peptides, drawing on current evidence and highlighting methodological limitations.
Absence of observed toxicity in animal studies of BPC-157 does not establish its safety in humans. Differences in metabolism, physiology, and exposure duration between species, as well as the lack of robust human clinical data, mean that animal findings cannot be directly extrapolated to human safety. Current evidence highlights the need for caution and further research before drawing conclusions about human risk.
The elevated plus maze (EPM) is a validated behavioral assay for assessing anxiety-like behaviors in rodents. In Selank rat studies, EPM endpoints—such as time spent in open versus closed arms—serve as quantitative measures of anxiety, not direct clinical outcomes. This article reviews the experimental design, measured endpoints, and interpretation of EPM data in the context of Selank research, emphasizing methodological strengths, limitations, and the boundaries of preclinical inference.
This article examines what ascorbate consumption measures in the context of a key in vitro study on Semax, copper, and amyloid-β, and highlights the method's strengths and limitations for peptide research interpretation.
A technical review on how to critically separate hypothesized from established uses of thymosin alpha-1 in narrative reviews, with a focus on research methods, clinical trial evidence, and the limitations of current data.
This resource examines the meaning and significance of epithelial-mesenchymal transition (EMT) and fibrosis-associated markers in the context of an in vitro study investigating Epitalon’s effects on human retinal pigment epithelial cells under high-glucose conditions. It details the experimental findings, the roles of EMT and fibrosis in diabetic retinopathy models, and the limitations of translating these results to clinical contexts.
This article explains the scientific concepts of limit of detection (LOD) and limit of quantification (LOQ) as applied to TB-500 peptide research. It distinguishes these analytical parameters, discusses their relevance in interpreting study abstracts, and highlights methodological limitations and uncertainties based on current evidence.
A systematic review of BPC-157 research offers a structured synthesis of preclinical and limited clinical findings, highlighting mechanisms, outcomes, and safety data while clarifying the limitations and uncertainties that individual studies cannot address alone.
This article examines the core research questions that differentiate small molecule and peptide drug candidates, focusing on their discovery, optimization, and development challenges. Evidence from recent reviews is used to clarify how these questions shape experimental design and translational hurdles.
The sequence in which Semax, copper ions, and ascorbate are combined in redox experiments critically affects copper redox cycling, reactive oxygen species (ROS) production, and peptide-metal complex formation. This resource analyzes in vitro evidence, mechanistic details, and experimental limitations, providing a technical framework for interpreting such studies.
A technical review of how patient selection and concurrent therapies influence the interpretation of thymosin alpha-1 peptide studies, with a focus on methodological rigor, evidence limitations, and the importance of context in research outcomes.
